Drug Therapy Protocols: Glucose 5%
Disclaimer and copyright
©2016 Queensland Government
All rights reserved. Without limiting the reservation of copyright, no person shall reproduce, store in a
retrieval system or transmit in any form, or by any means, part or the whole of the Queensland Ambulance
Service (‘QAS’) Clinical practice manual (‘CPM’) without the priorwritten permission of the Commissioner.
The QAS accepts no responsibility for any modification, redistribution or use of the CPM or any part
thereof. The CPM is expressly intended for use by QAS paramedics whenperforming duties and delivering
ambulance services for, and on behalf of, the QAS.
Under no circumstances will the QAS, its employees or agents, be liable for any loss, injury, claim, liability
or damages of any kind resulting from the unauthorised use of, or reliance upon the CPM or its contents.
While effort has been made to contact all copyright owners this has not always been possible. The QAS
would welcome notification from any copyright holder who has been omitted or incorrectly acknowledged.
All feedback and suggestions are welcome, please forward to:
[email protected]
Date
October, 2015
Purpose
Scope
Author
To ensure a consistent procedural approach to Glucose 5% administration.
Applies to all QAS clinical staff.
Clinical Quality & Patient Safety Unit, QAS
Review date
October, 2017
URL
https://ambulance.qld.gov.au/clinical.html
This work is licensed under the Creative Commons
Attribution-NonCommercial-NoDerivatives 4.0
International License. To view a copy of this license,
visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Glucose 5%
October, 2015
Drug class
Side effects
Pharmocological dilutant
UNCONTROLLED WHEN PRINTED
Pharmacology
• Nil
Glucose is a sugar that is the principal energy source for body cells,
especially the brain.[1] Metabolism
Broken down in most tissues and distributed throughout total body water.[1]
Presentation
• Viaflex® plastic container, 100 mL, glucose 5%
UNCONTROLLED WHEN PRINTED
Indications
• As a vehicle for drug delivery during IV/IO drug infusion administration
Onset
Duration
Half-life
Not applicable
Not applicable
Not applicable
• For the dilution and reconstitution of medications
UNCONTROLLED WHEN PRINTED
Schedule
• Nil
• Unscheduled.
Routes of administration
Intravenous injection (IV)
CCP
Contraindications
Intravenous infusion (IV INF)
CCP
UNCONTROLLED WHEN PRINTED
Precautions
Intraosseous injection (IO)
Figure 4.15
CCP
• Hyperglycaemia
QUEENSLAND AMBULANCE SERVICE
759
Glucose 5%
Adult dosages
• As a vehicle for drug delivery during IV/IO drug infusion administration
UNCONTROLLED WHEN PRINTED
CCP
• For the dilution and reconstitution of medications
IV/IO
INF
As authorised on individual DTPs
UNCONTROLLED WHEN PRINTED
Paediatric dosages
• As a vehicle for drug delivery during IV/IO drug infusion administration
• For the dilution and reconstitution of medications
CCP
UNCONTROLLED WHEN PRINTED
IV/IO
INF
As authorised on individual DTPs
UNCONTROLLED WHEN PRINTED
Special notes
• Following medication dilution/reconstitution all unused
glucose 5% solution should be discarded immediately.
760